Abstract

Chronic NF-κB activation in inflammation and cancer has long been linked to persistent activation of NF-κB–responsive gene promoters. However, NF-κB factors also massively bind to gene bodies. Here, we demonstrate that recruitment of the NF-κB factor RELA to intragenic regions regulates alternative splicing upon NF-κB activation by the viral oncogene Tax of HTLV-1. Integrative analyses of RNA splicing and chromatin occupancy, combined with chromatin tethering assays, demonstrate that DNA-bound RELA interacts with and recruits the splicing regulator DDX17, in an NF-κB activation-dependent manner. This leads to alternative splicing of target exons due to the RNA helicase activity of DDX17. Similar results were obtained upon Tax-independent NF-κB activation, indicating that Tax likely exacerbates a physiological process where RELA provides splice target specificity. Collectively, our results demonstrate a physical and direct involvement of NF-κB in alternative splicing regulation, which significantly revisits our knowledge of HTLV-1 pathogenesis and other NF-κB-related diseases.

The nuclear factors κB (NF-κB) is a transcription factor involved in immune functions, inflammation, and cancer. Here, the authors show that the NF-κB factor RELA regulates splicing of target genes by recruiting DDX17 on chromatin upon expression of the viral oncogene Tax.

Details

Title
Intragenic recruitment of NF-κB drives splicing modifications upon activation by the oncogene Tax of HTLV-1
Author
Ameur, Lamya Ben 1   VIAFID ORCID Logo  ; Paul, Marie 1   VIAFID ORCID Logo  ; Morgan, Thenoz 2 ; Giraud Guillaume 1 ; Combe, Emmanuel 1   VIAFID ORCID Logo  ; Jean-Baptiste, Claude 1 ; Lemaire Sebastien 1 ; Fontrodona Nicolas 1 ; Polveche Hélène 3 ; Bastien Marine 4 ; Gessain Antoine 5 ; Wattel, Eric 6   VIAFID ORCID Logo  ; Bourgeois, Cyril F 1   VIAFID ORCID Logo  ; Auboeuf Didier 1   VIAFID ORCID Logo  ; Mortreux Franck 1   VIAFID ORCID Logo 

 Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, Lyon, France (GRID:grid.15140.31) (ISNI:0000 0001 2175 9188) 
 Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, Lyon, France (GRID:grid.15140.31) (ISNI:0000 0001 2175 9188); Faculty of Medicine and Health Sciences, Department of Pediatrics and Medical Genetics, Gent, Belgium (GRID:grid.15140.31) 
 CECS, I-Stem, Corbeil-Essonnes, France (GRID:grid.503216.3) (ISNI:0000 0004 0618 2124) 
 Univ Lyon, ENS de Lyon, Univ Claude Bernard, CNRS UMR 5239, INSERM U1210, Laboratory of Biology and Modelling of the Cell, Lyon, France (GRID:grid.15140.31) (ISNI:0000 0001 2175 9188); School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK (GRID:grid.4425.7) (ISNI:0000 0004 0368 0654) 
 Unité dʼEpidémiologie et Physiopathologie des Virus Oncogénes, Institut Pasteur, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535) 
 Université Lyon 1, CNRS UMR5239, Oncovirologie et Biothérapies, Faculté de Médecine Lyon Sud, ENS - HCL, Pierre Bénite, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757); Université Lyon 1, Service dʼHématologie, Pavillon Marcel Bérard, Centre Hospitalier Lyon-Sud, Pierre Bénite, France (GRID:grid.7849.2) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2413787279
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.